Shelcal 250 Tablet 30’s

If
you are known to be allergic to Shelcal 250 Tablet 30’s or any other
medicines, please tell your doctor. If you are pregnant or planning to
become pregnant, it is advised to inform your doctor before using
Shelcal 250 Tablet 30’s. Higher doses of Vitamin D than the recommended
daily dose should be used in pregnant women only when advised by the
doctor. Cholecalciferol in higher doses may harm the foetus. Shelcal 250
Tablet 30’s may pass into the breast milk, hence consult your doctor
before taking Shelcal 250 Tablet 30’s if you are a breastfeeding mother.
Shelcal 250 Tablet 30’s should be used with caution in children and
only if prescribed by a doctor. Cholecalciferol in Shelcal 250 Tablet
30’s can affect growth in children. Inform your doctor if your child is
not growing at a normal rate while using Shelcal 250 Tablet 30’s.
Shelcal 250 Tablet 30’s is not recommended if you have hypercalcemia
(high calcium levels), metastatic calcification (extra deposits of
calcium in the body), hypervitaminosis D (high vitamin D levels), and
malabsorption syndrome (difficulty absorbing nutrition from food).
Inform your doctor before taking Shelcal 250 Tablet 30’s if you have any
heart/kidney/liver/blood vessel diseases, kidney stones, sarcoidosis
(growth of inflammatory cells in different parts of the body), Crohn’s
disease (inflammatory bowel disease), Whipple’s disease (bacterial
infection affecting joints and digestive system), achlorhydria (little
or no stomach acid), low levels of bile, and phosphate imbalance.
Shelcal 250 Tablet 30’s contains sugar or sorbitol; hence caution should
be taken to have an intolerance to sugars, diabetes, and
phenylketonuria (increased levels of an amino acid called
phenylalanine).

Drug-Drug Interactions: Shelcal
250 Tablet 30’s may interact with calcium supplements (ergocalciferol,
calcitriol), drugs treating bone loss (alendronate), diuretics
(bendroflumethiazide, chlortalidone, indapamide), a drug used to treat
heart disease (digoxin), antacids (magnesium hydroxide), steroid
medicines (hydrocortisone, prednisolone, dexamethasone), central nervous
system stimulants (dextroamphetamine, amphetamine), anti-depressants
(duloxetine), minerals (ferrous sulfate), anti-ulcer drugs (ranitidine),
synthetic thyroid hormone (levothyroxine), painkillers (aspirin),
anti-clotting drugs (anisindione, dicumarol, warfarin), drugs treating
high cholesterol levels (cholestyramine, colesevelam, colestipol), and
drugs that treat high blood phosphorus levels (sevelamer), antibiotics
(tetracycline, doxycycline, minocycline), quinolone antibiotics
(ciprofloxacin, levofloxacin), weight-loss drugs (orlistat), and
anti-cancer medication (estramustine).

Drug-Food Interactions: Avoid or reduce the intake of caffeine, soft drinks, and alcohol that inhibit calcium absorption.

Drug-Disease Interactions: Shelcal
250 Tablet 30’s is contraindicated in hypercalcemia (high calcium level
in blood), hypervitaminosis D (high vitamin D level in the body),
Vitamin D toxicity, malabsorption syndrome, heart/kidney/liver/blood
vessel diseases, kidney stones, sarcoidosis (growth of tiny collections
of inflammatory cells (granulomas) in any part of your body), Crohn’s
disease, Whipple’s disease (a bacterial infection that most often
affects joints and digestive system), achlorhydria (absence of stomach
acid), low levels of bile, and phosphate imbalance. 

• Include dairy products like milk, yoghurt, cheese, or milk-based custard in your diet.
• Eat daily a serving of broccoli, cabbage, bok choy, spinach, and other green leafy vegetables.
• Snack on calcium-rich nuts like Brazil nuts or almonds.
• Sprinkle sesame seeds over your food, vegetables, and salads. Sesame seeds are high in calcium.
• Avoid or reduce the intake of caffeine, soft drinks, and alcohol that inhibit calcium absorption.
• Replace the meat with tofu for extra calcium in your food.

• Clinical monitoring of serum electrolyte concentrations and cardiac function is recommended.
• A low phosphate diet is recommended to control serum phosphorus levels in patients undergoing dialysis.